An update on the pharmacological management of hyperthyroidism due to Graves' disease (Q36161238)

12 August 2017

1 reference

title

An update on the pharmacological management of hyperthyroidism due to Graves' disease (English)

1 reference

12 August 2017

3

Fausto Bogazzi

1 reference

12 August 2017

Luigi Bartalena

1

1 reference

12 August 2017

Maria Laura Tanda

2

1 reference

12 August 2017

Eliana Piantanida

4

1 reference

12 August 2017

Adriana Lai

5

1 reference

12 August 2017

Enio Martino

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

851-861

1 reference

Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

Rapid preoperative preparation for severe hyperthyroid Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

The use of oral radiographic contrast agents in the management of hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

Adverse effects of thyroid hormone preparations and antithyroid drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

Severe embryopathy and exposure to methimazole in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

A comparison of 20 or 40 mg per day of carbimazole in the initial treatment of hyperthyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

Iopanoic acid in the management of neonatal Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.851

21 January 2018

Identifiers

DOI

10.1517/14656566.6.6.851

1 reference

12 August 2017

1 reference